<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04901845</url>
  </required_header>
  <id_info>
    <org_study_id>IC4-05682-009-GEO</org_study_id>
    <nct_id>NCT04901845</nct_id>
  </id_info>
  <brief_title>VEIN Health - CVD Prevalence and Characteristics</brief_title>
  <official_title>VEIN Health Chronic Venous Disease at Primary and Specialized Healthcare Level -Update on Prevalence and Characteristics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bokhua Memorial Cardiovascular Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Chapidze Emergency Cardiology Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Bokhua Memorial Cardiovascular Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Epidemiology Study to learn prevalence and characteristics of CVD at Primary and Specialized&#xD;
      healthcare level&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cross sectional study that will evaluate prevalence, characteristics, diagnostic and&#xD;
      treatment status of the patients with Chronic Venous Disease at primary or specialized&#xD;
      healthcare level during 2 week period. No interventions are made. Information on patient&#xD;
      demographic, physical, clinical parameters, medical history data and procedures performed&#xD;
      during visit in routine daily practice of physicians is registered and analyzed.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 2021</start_date>
  <completion_date type="Anticipated">September 2021</completion_date>
  <primary_completion_date type="Anticipated">June 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of CVD</measure>
    <time_frame>2 weeks</time_frame>
    <description>Percent of CVD symptomatic patients among patients applying to consultation for any reason</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Distribution of CEAP stages</measure>
    <time_frame>2 weeks</time_frame>
    <description>Percent of CVD patients with various CEAP stages</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Prevalence of risk-factors associated with CVD</measure>
    <time_frame>2 weeks</time_frame>
    <description>Frequency of risk-factors associated with CVD</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Management tactics</measure>
    <time_frame>2 weeks</time_frame>
    <description>Tactics chosen by physicians to manage CVD</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">10000</enrollment>
  <condition>Chronic Venous Disease</condition>
  <arm_group>
    <arm_group_label>Patients applying to Primary Healthcare Consultation</arm_group_label>
    <description>Consequent patients applying to the Primary healthcare to consult for any reason during 2 week period</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients applying to Specialized Healthcare Consultation</arm_group_label>
    <description>Consequent patients applying to the Specialized healthcare to consult for any reason during 2 week period</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention provided</intervention_name>
    <description>Study is provided in the usual daily practice of the physicians without interventions made in their practice</description>
    <arm_group_label>Patients applying to Primary Healthcare Consultation</arm_group_label>
    <arm_group_label>Patients applying to Specialized Healthcare Consultation</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients applying to consultation due to any reason&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age above 18 years&#xD;
&#xD;
          -  Patient consented to participate&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient applying due to emergency situation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nugzar Pargalava, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Bokhua Memorial Cardiovascular Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Zaza Lazarahvili, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Chapidze Emergency Cardiology Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mamuka Bokuchava, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Bokhua Memorial Cardiovascular Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mamuka Bokuchava, MD, PhD</last_name>
    <phone>+995577434075</phone>
    <email>bmamuka@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Manana Silagava, MD</last_name>
    <phone>+995599091728</phone>
    <email>mano.silagava@yahoo.com</email>
  </overall_contact_backup>
  <reference>
    <citation>Shabani Varaki E, Gargiulo GD, Penkala S, Breen PP. Peripheral vascular disease assessment in the lower limb: a review of current and emerging non-invasive diagnostic methods. Biomed Eng Online. 2018 May 11;17(1):61. doi: 10.1186/s12938-018-0494-4. Review.</citation>
    <PMID>29751811</PMID>
  </reference>
  <reference>
    <citation>Nicolaides A, Kakkos S, Baekgaard N, Comerota A, de Maeseneer M, Eklof B, Giannoukas AD, Lugli M, Maleti O, Myers K, Nelz√©n O, Partsch H, Perrin M. Management of chronic venous disorders of the lower limbs. Guidelines According to Scientific Evidence. Part I. Int Angiol. 2018 Jun;37(3):181-254. doi: 10.23736/S0392-9590.18.03999-8.</citation>
    <PMID>29871479</PMID>
  </reference>
  <reference>
    <citation>Gloviczki P, Comerota AJ, Dalsing MC, Eklof BG, Gillespie DL, Gloviczki ML, Lohr JM, McLafferty RB, Meissner MH, Murad MH, Padberg FT, Pappas PJ, Passman MA, Raffetto JD, Vasquez MA, Wakefield TW; Society for Vascular Surgery; American Venous Forum. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg. 2011 May;53(5 Suppl):2S-48S. doi: 10.1016/j.jvs.2011.01.079.</citation>
    <PMID>21536172</PMID>
  </reference>
  <reference>
    <citation>Rabe E, Guex JJ, Puskas A, Scuderi A, Fernandez Quesada F; VCP Coordinators. Epidemiology of chronic venous disorders in geographically diverse populations: results from the Vein Consult Program. Int Angiol. 2012 Apr;31(2):105-15.</citation>
    <PMID>22466974</PMID>
  </reference>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 5, 2021</study_first_submitted>
  <study_first_submitted_qc>May 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 26, 2021</study_first_posted>
  <last_update_submitted>May 23, 2021</last_update_submitted>
  <last_update_submitted_qc>May 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bokhua Memorial Cardiovascular Center</investigator_affiliation>
    <investigator_full_name>Mamuka Bokuchava</investigator_full_name>
    <investigator_title>TSSU Professor; Deputy Director of Bokhua Memorial Cardiovascular Center</investigator_title>
  </responsible_party>
  <keyword>Chronic Venous Disease</keyword>
  <keyword>Prevalence</keyword>
  <keyword>Characteristics</keyword>
  <keyword>Management tactics evaluation</keyword>
  <keyword>Risk-factors</keyword>
  <keyword>Distribution of CEAP stages</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

